Last reviewed · How we verify

NCT04376294

Using of Extracorporeal Shockwave Therapy in Treatment Of Achilles Tendinopathy

Completed NA Last updated 17 July 2020
What this trial tests

NA trial testing Extracorporeal Shockwave Therapy(ESWT) in Achilles Tendinopathy in 50 participants. Completed in 1 June 2020.

Timeline
1 October 2018
Primary endpoint
31 December 2018
1 June 2020

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date1 October 2018
Primary completion31 December 2018
Estimated completion1 June 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 40, any sex, with Achilles Tendinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to determine the effect of extracorporeal Shock wave therapy (ESWT) on functional activity and pain in patients with Achilles tendinopathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Achilles Tendinopathy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04376294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing